WOLFRAM E SAMLOWSKI MD NPI 1396810834

NPI Information

  • NPI: 1396810834
  • Provider Name: WOLFRAM E SAMLOWSKI, MD
  • Classification: Internal Medicine - 207RH0003X
  • Specialization: Hematology & Oncology
  • Entity Type: Individual
  • PECOS Registration: Yes
  • Address: 2050 PINTO LN STE 200
    LAS VEGAS, NV
    ZIP 89106
  • Phone: (702) 473-1757

Map and Directions

Get Directions

NPI Details

Wolfram E Samlowski, MD is a hematology and oncology internal medicine in Las Vegas, NV with 48 years of experience. The provider is an internist doctor of osteopathy that specializes in the treatment of the combination of hematology and oncology disorders. A doctor of osteopathy that is board eligible/certified by the American Osteopathic Board of Internal Medicine WAS able to obtain a Certificate of Special Qualifications in the field of Hematology and Oncology. The Certificate is NO longer offered. Wolfram E Samlowski, MD NPI is 1396810834. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a male.

Education
Medical School: OHIO STATE UNIVERSITY COLLEGE OF MEDICINE
Graduation Year:1978

The provider's business location address is:

2050 PINTO LN STE 200
LAS VEGAS, NV
ZIP 89106-019
Phone: (702) 473-1757
Fax: (702) 725-4348

The NPI 1396810834 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

  • Injection, pembrolizumab, 1 mg (HCPCS:J9271)
  • Injection, nivolumab, 1 mg (HCPCS:J9299)
  • Injection, filgrastim-sndz, biosimilar, (zarxio), 1 microgram (HCPCS:Q5101)
  • Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) (HCPCS:Q0138)
  • Injection, darbepoetin alfa, 1 microgram (non-esrd use) (HCPCS:J0881)
  • Injection, fosaprepitant, 1 mg (HCPCS:J1453)
  • Injection, paclitaxel, 1 mg (HCPCS:J9267)
  • Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml (HCPCS:Q9967)
  • Injection, dexamethasone sodium phosphate, 1 mg (HCPCS:J1100)
  • Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count (HCPCS:85025)
  • Insertion of needle into vein for collection of blood sample (HCPCS:36415)
  • Injection, granisetron hydrochloride, 100 mcg (HCPCS:J1626)
  • Injection, denosumab, 1 mg (HCPCS:J0897)
  • Lactate dehydrogenase (enzyme) level (HCPCS:83615)
  • Blood test, comprehensive group of blood chemicals (HCPCS:80053)
  • Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
  • Injection, palonosetron hcl, 25 mcg (HCPCS:J2469)
  • Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
  • Injection, gemcitabine hydrochloride, not otherwise specified, 200 mg (HCPCS:J9201)
  • Administration of chemotherapy into vein, 1 hour or less (HCPCS:96413)
  • Thyroxine (thyroid chemical), free (HCPCS:84439)
  • Injection of additional new drug or substance into vein (HCPCS:96375)
  • Blood test, thyroid stimulating hormone (tsh) (HCPCS:84443)
  • Injection, carboplatin, 50 mg (HCPCS:J9045)
  • Gammaglobulin (immune system protein) measurement (HCPCS:82784)
  • Injection of drug or substance under skin or into muscle (HCPCS:96372)
  • Red blood cell sedimentation rate, to detect inflammation, automated (HCPCS:85652)
  • Administration of chemotherapy into vein, each additional hour (HCPCS:96415)
  • Injection, diphenhydramine hcl, up to 50 mg (HCPCS:J1200)
  • Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96401)
  • Administration of additional new drug or substance into vein, 1 hour or less (HCPCS:96417)
  • Nephelometry, test method using light (HCPCS:83883)
  • Injection, zoledronic acid, 1 mg (HCPCS:J3489)
  • Ferritin (blood protein) level (HCPCS:82728)
  • Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less (HCPCS:96367)
  • Iron level (HCPCS:83540)
  • Blood test, clotting time (HCPCS:85610)
  • Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less (HCPCS:96365)
  • Follow-up hospital inpatient care per day, typically 35 minutes (HCPCS:99233)
  • Injection of drug or substance into vein (HCPCS:96374)
  • Iron binding capacity (HCPCS:83550)
  • Carcinoembryonic antigen (cea) protein level (HCPCS:82378)
  • Infusion into a vein for therapy, prevention, or diagnosis, each additional hour (HCPCS:96366)
  • Immunologic analysis technique on serum (immunofixation) (HCPCS:86334)
  • Protein measurement, serum (HCPCS:84165)
  • New patient office or other outpatient visit, 60-74 minutes (HCPCS:99205)
  • Psa (prostate specific antigen) measurement, total (HCPCS:84153)
  • Unclassified drugs (HCPCS:J3490)
  • Leuprolide acetate (for depot suspension), 7.5 mg (HCPCS:J9217)
  • New patient office or other outpatient visit, 45-59 minutes (HCPCS:99204)
  • Immunologic analysis for detection of tumor antigen, quantitative; ca 15-3 (HCPCS:86300)
  • Infusion into a vein for hydration, each additional hour (HCPCS:96361)
  • Magnesium level (HCPCS:83735)
  • Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96402)
  • Infusion, normal saline solution, sterile (500 ml = 1 unit) (HCPCS:J7040)
  • Infusion, normal saline solution , 1000 cc (HCPCS:J7030)
  • Ct scan of chest with contrast (HCPCS:71260)
  • Infusion into a vein for hydration, 31-60 minutes (HCPCS:96360)
  • Initial hospital inpatient care per day, typically 70 minutes (HCPCS:99223)
  • Beta-2 microglobulin (protein) level (HCPCS:82232)
  • Ct scan of abdomen and pelvis with contrast (HCPCS:74177)
  • Injection, morphine sulfate, up to 10 mg (HCPCS:J2270)
  • Measurement c-reactive protein for detection of infection or inflammation (HCPCS:86140)
  • Ct scan of chest without contrast (HCPCS:71250)
  • Red blood count, automated test (HCPCS:85045)
  • Administration of additional new drug or substance into vein using push technique (HCPCS:96411)
  • Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg (HCPCS:J3420)
  • Cyanocobalamin (vitamin b-12) level (HCPCS:82607)
  • Manual urinalysis test with examination using microscope, non-automated (HCPCS:81000)
  • Folic acid level, serum (HCPCS:82746)
  • Irrigation of implanted venous access drug delivery device (HCPCS:96523)
  • Established patient office or other outpatient visit, 40-54 minutes (HCPCS:99215)

The enumeration date for this NPI number is 11/21/2006 and was last updated on 9/5/2025.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

No. Taxonomy Code Taxonomy Clasification Taxonomy Specialization License Number License State Primary
1207RH0003XInternal MedicineHematology & Oncology166160-1205UTAHNo
2207RH0003XInternal MedicineHematology & Oncology12318NEVADAYes

Other Identifiers

The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.

No. Other Provider Identifier Other Provider Identifier Type Other Provider Identifier State Other Provider Identifier Issuer
111742205OTHERNEVADACAQH PROVIDER ID

What is NPI?

NPI stands for National Provider Identifier. The NPI is a 10-digit identification number that is completely unique. The NPI number by itself does not contain any identifiable information such as a provider’s speciality or location. The NPI is assigned to individuals or organizacions for their lifespan and it is independent of key provider information type updates like a change of practices, location or speciality.

This page was last updated on: 11/21/2025

NPI Synchronization or Removal

All materials and services on this site are provided on an "as is" and "as available" basis without warranty of any kind. The NPI record is maintained by the National Plan & Provider Enumeration System (NPPES) and anyone may request this information and other NPPES health care provider data from HHS under The Freedom of Information Act (FOIA), Title 5 of the United States Code, section 552. To update the NPI records please contact the NPPES.